Title of article :
Dexmedetomidine: An All Sedation-in–One Drug in Critically Ill Patients with COVID-19
Author/Authors :
Mahmoodpoor, Ata Department of Anesthesiology and Critical Care - Faculty of Medicine - Tabriz University of Medical Sciences, Tabriz, Iran , Ekrami, Elyad Tabriz University of Medical Sciences, Tabriz, Iran , Soleimanpour, Hassan Tabriz University of Medical Sciences, Tabriz, Iran
Pages :
2
From page :
80
To page :
81
Abstract :
The coronavirus disease 19 (COVID-19) caused by SARSCoV-2 emerged as a public health threat in December 2019 and spread as a pandemic in March 2020. The virus can invade both respiratory and central nervous systems and can result in significant organ dysfunction. COVID-19 associated respiratory distress syndrome is an acute hypoxemic event which requires respiratory assistant. Hypoxemia itself and ventilation support (invasive or noninvasive) can induce agitation and require appropriate management. Direct invasion of virus to CNS can induce inflammation and delirium in these patients which requires accordance treatment.
Keywords :
Dexmedetomidine , COVID-19 , ICU
Journal title :
Pharmaceutical Sciences
Serial Year :
2020
Record number :
2522278
Link To Document :
بازگشت